Midway through trading Wednesday, the Dow traded up 1.79% to 26380.13 while the NASDAQ rose 1.35% to 8,801.49. The S&P also fell, dropping 1.48% to 3,047.75. Coronavirus cases continued to rise outside China. South Korea confirmed 516 new coronavirus cases on Wednesday, while Iran reported 586 new infections of coronavirus since Tuesday. Mainland China reported 119 new confirmed cases on March 3, down from 125 cases on March 2.
Leading and Lagging Sectors
In trading on Wednesday, financial shares rose by just 0.2%.
Dollar Tree, Inc. (NASDAQ: DLTR) reported upbeat earnings for its fourth quarter, while sales missed estimates. The company also issued weak forecast for the first quarter.
Dollar Tree reported fourth-quarter earnings of $1.79 per share on Wednesday, which beat the analyst consensus estimate of $1.75. The company reported quarterly sales of $6.32 billion, which missed the analyst consensus estimate of $6.39 billion.
Dollar Tree sees first-quarter EPS of $1-$1.09 versus the $1.20 estimate and sales of $5.89-$5.99 billion versus the $6.03 billion estimate. The company sees fiscal year 2020 EPS of $4.80-$5.15 versus the $4.72 estimate and sales of $24.21-$24.66 billion versus the $23.68 million estimate.
Equities Trading UP
Cellect Biotechnology Ltd. (NASDAQ: APOP) shares shot up 43% to $2.9850. The Israeli company said it has entered into a commercial binding Letter of Intent with medical cannabis company Cannadoc to acquire all rights to the use of Cannadoc products for the reduction of opioid use, including accumulated data as well as ongoing and pipeline of clinical trials.
Shares of AIM ImmunoTech Inc. (NYSE: AIM) got a boost, shooting 32% to $2.4101 after Joe Biden secured several key wins in Super Tuesday. Biden's more 'moderate' healthcare policies have been seen as more favorable for the sector.
Ocular Therapeutix, Inc. (NASDAQ: OCUL) shares were also up, gaining 25% to $6.84. Raymond James upgraded Ocular Therapeutix from Outperform to Strong Buy and raised the price target from $7 to $15.
Equities Trading DOWN
Cardlytics, Inc. (NASDAQ: CDLX) shares tumbled 33% to $57.36 after the company reported Q4 earnings results and disclosed an executive shakeup. Craig-Hallum also downgraded the stock from Buy to Hold.
Shares of Recro Pharma, Inc. (NASDAQ: REPH) were down 26% to $10.55 after the company reported results for the year ended 2019.
Owens & Minor, Inc. (NYSE: OMI) was down, falling 21% to $5.30 after the company reported worse-than-expected Q4 sales. The company also issued FY20 EPS guidance below analyst estimates.
In commodity news, oil traded up 1.2% to $47.73, while gold traded down 0.1% to $1,643.90.
Silver traded down 0.2% Wednesday to $17.155, while copper rose 0.1% to $2.574.
European shares were higher today. The eurozone’s STOXX 600 rose 1.02% the Spanish Ibex Index rose 0.61%, while Italy’s FTSE MIB Index climbed 0.5% Meanwhile, the German DAX gained 0.76%, and the French CAC 40 rose 0.93% while UK shares rose 1.22%.
Private businesses hired 183,000 workers in February, versus a revised 209,000 gain in the earlier month.
The IHS Markit services PMI came in at 49.4 for February, versus a reading of 53.4 in the previous month.
The ISM non-manufacturing PMI climbed to 57.3 in February, compared to 55.5 in the prior month.
U.S. crude supplies climbed 785,000 barrels for the week ended February 28, the Energy Information Administration reported. However, analysts expected a gain of 3.5 million barrels.
The Federal Open Market Committee will release its Beige Book report at 2:00 p.m. ET.
Federal Reserve Bank of St. Louis President James Bullard is set to speak at 6:30 p.m. ET.